Table 3. The relationship between PE and LGL lymphocytosis.
Reference | PE | |
---|---|---|
LGL+ | LGL− | |
Mustjoki et al.15 | 13/22 (59%) | NR |
Nagata et al.17 | 5/9 (56%) | 3/11 (27%) |
Tanaka et al.19 | 9/15 (60%) | 2/10 (20%) |
Lee et al.21 | 5/23 (22%) | 6/27 (22%) |
Powers et al.22 | 3/5 (60%) | 2/11 (18%) |
PE, pleural effusions; NR, not reported.